10 biotech executives

Experience: CEO and President · Phare Bio

CEO and President at Phare Bio since 2021; the profile describes Phare Bio as a biotech social venture using AI and deep learning to develop novel antibiotics in partnership with the Collins Lab at MIT. Other roles include Co-Founder and CEO at Variant Bio (2018–2020), EIR at Lux Capital (2020–2021) and Lecturer Senior Advisor at Stanford University (since 2017).

Experience: Chief Executive Officer, founder, Board of Directors · Vedanta Biosciences, Inc.

Chief Executive Officer, founder, Board of Directors at Vedanta Biosciences, Inc. since 2015, and listed as Founder of Vedanta Biosciences, Inc. for 2012–2015. Other roles include Venture Partner at PureTech Health (2007–2016) and Co-Founder at Follica, Inc. (2007–2015).

Experience: President and Chief Executive Officer · Walden Biosciences

President and Chief Executive Officer at Walden Biosciences since 2020; the profile describes building biotechnology companies in both large and start-up settings. Former roles include Executive Vice President and Chief Business Officer at ImmunoGen, Inc. (2018–2019), Senior Vice President, Head of Corporate Development (2016–2018) and Senior Vice President, Head of Transactions (2014–2016) at Shire, and Executive Vice President and Chief Business Officer at 480 BIOMEDICAL (2011–2014).

Experience: Chief Executive Officer · AbCellera

Chief Executive Officer at AbCellera since 2012; the profile describes AbCellera (ABCL) as a biotechnology research company. He was Professor at The University of British Columbia (2005–2019) and has been Adjunct Professor there since 2019, and he was Co-founder & Director (2011–2015) and Scientific Advisor (2015–2021) at Precision NanoSystems, Inc.

Experience: Chief Executive Officer · Nona Biosciences

Chief Executive Officer at Nona Biosciences since 2025, a company the profile describes as a biotechnology research company that pioneers fully human heavy chain only antibodies (HCAb/VHH). Former roles include Chief Executive Officer at Gaoyue （高岳）Life Science Group (Hillhouse Rava) (2022–2025), Vice President, Corporate Operation & Strategic Alliance at Hua Medicine (2021–2022) and Head of Operations Member of Senior Management Committee at Amgen (2014–2019).

Experience: President, Chief Executive Officer, and Board Member · AltruBio Inc.

President, Chief Executive Officer, and Board Member at AltruBio Inc. since 2020. She was Global Head of Biotech & Senior Vice President, and Bayer Berkeley Site Head at Bayer (2017–2020) and was on the Board Of Directors, Bayer Fund (2017–2020); she also lists Board Member at Akero Therapeutics (since 2021) and Governing Board Member at the California Institute for Regenerative Medicine (CIRM) (since 2022).

Experience: CEO and Founder Board Co-Chair · Altos Labs

CEO and Founder Board Co-Chair at Altos Labs since 2022; the profile describes Altos Labs as a biotechnology company focused on restoring cell health and resilience through cell rejuvenation. Former roles are Chief Scientific Officer and President, Research & Development at GSK (2018–2022), President, Research & Development at Calico Life Sciences (2014–2017), Executive Vice President, Head of Global Product Development & Chief Medical Officer at Roche (2009–2014) and Senior Vice President of Development, Chief Medical Officer at Genentech (2003–2009).

Experience: President and CEO · eGenesis

President and CEO at eGenesis since 2022, a company the profile describes as a biotechnology research company; he was President of R&D at eGenesis (2020–2022). At Cadent Therapeutics he was President and CEO (2014–2019), President and Head of R&D (2019–2020) and Senior Advisor (2020).

Experience: President and Chief Operating Officer · Twist Bioscience

President and Chief Operating Officer at Twist Bioscience since 2022; the profile describes Twist as a synthetic biology company that specializes in gene synthesis and oligo pools. Former Twist Bioscience roles are Chief Commercial Officer (2019–2022) and SVP Commercial Operations (2015–2019); he also lists Board Member at ONI (since 2021) and Board Member at Revelar Biotherapuetics (2021–2022).

Experience: Chief Executive Officer · Triveni Bio

Chief Executive Officer at Triveni Bio since 2022; the profile describes Triveni Bio as a privately held, clinical-stage biotechnology company developing antibody therapeutics for immunological and inflammatory (I&I) disorders. He also lists Entrepreneur In Residence at Atlas Venture (since 2022), Board Member at Leonardo (since 2025) and Joint Reserve Officer at the Defense Innovation Unit (DIU) (since 2023).